Keyword Connections

chimeric antigen receptor

Journals

4

1 transfusion

2 Haematologica

3 biotechnology journal

4 european urology

Research Groups

0

No Research Group Connected

Bibliographies

18

1 Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

2 engineering cytoplasmic signaling of cd28ζ cars for improved therapeutic functions

3 advancing car t-cell therapy for solid tumors: lessons learned from lymphoma treatment

4 in vivo murine-matured human cd3+ cells as a preclinical model for t cell-based immunotherapies

5 redirected primary human chimeric antigen receptor natural killer cells as an “off-the-shelf immunotherapy” for improvement in cancer treatment

6 from igg fusion proteins to engineered-specific human regulatory t cells: a life of tolerance

7 foreign or domestic cars: receptor ligands as antigen-binding domains

8 Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology.

9 [The evaluation of modified cell infusion method to reduce febrile non-hemolytic transfusion reaction in CD(19) chimeric antigen receptor T cell threapy].

10 Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

11 Author Correction: Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains (Nature Communications, (2020), 11, 1, (283), 10.1038/s41467-019-14119-9)

12 review of cancer immunotherapy: application of chimeric antigen receptor t cells and programmed death 1/programmed death-ligand 1 antibodies

13 chimeric antigen receptor t cell (car t cell) therapy in hematology

14 chimeric antigen receptor-modified t cells redirected to epha2 for the immunotherapy of non-small cell lung cancer

15 genetic engineering of chimeric antigen receptors using lamprey derived variable lymphocyte receptors

16 chimeric antigen receptor t-cell therapy for solid tumors

17 Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

18 Chimeric antigen receptor T cell immunotherapy in colorectal cancer: primetime yet?